Why BGPT?
logo

Check Claims Before You Publish

See how your reported results read as versioned evidence records — linked to experiments and limitations.Know what the science actually supports before you trust the answer.

Press Enter ↵ to review claims



    Explore by Goal












     Quick Explanation


    Scientific-strength snapshot for “David H Rich”
    Based on the provided OpenAlex matches (h-index/citation counts) and the limited paper list supplied, the author’s *measured* impact looks early-stage (few works + low h-index), with the main scientific signal being methodological/quantitative bioinformatics-style work (e.g., selection/mutation modeling; phylogenetic tree exploration; “larch”/MP-edge learning). Major caveat: the OpenAlex “matches” include disambiguation ambiguity (multiple similarly named entities, including a clearly non-matching “St Louis”), so precision of attribution is a key unknown.



     Long Explanation


    Author Review: David H Rich (evidence-weighted + skeptical)

    Epistemic status: attribution-limited Key risk: author-name disambiguation

    Known (from your provided metadata)

    • Provided citation metrics: h-index = 2; total citations = 5; paper count = 3; with 3 titled works listed by you. (Source: your provided author/metrics block.)
    • Provided OpenAlex matches: multiple candidate “David H Rich”-like entities appear, with one clearly different large historical profile (“St Louis”) and several smaller “David H Rich” profiles with low works/citations/h-index. (Source: OpenAlex query results you provided.)
    OpenAlex match evidence (disambiguation ambiguity):

    Visualization: citation footprint (as provided)

    Evidence note: these values are taken from your provided metadata block and are not independently verified here beyond the OpenAlex candidate record showing low h-index for one matching entity. Disambiguation remains the dominant uncertainty.

    Visualization: OpenAlex candidate landscape (provided matches)

    How to interpret: multiple candidate identities exist, so “David H Rich” attribution can easily drift. The “St Louis” high-impact record demonstrates the hazard of conflating different people with overlapping name strings. (OpenAlex evidence above.)

    Scientific strengths suggested by the provided paper list

    The paper titles you provided for the author are consistent with quantitative computational biology / computational evolution / protein- or sequence-centric modeling:
    • “Separating selection from mutation in antibody language models”: suggests mechanistic disentangling of evolutionary forces in generative modeling of antibody sequence evolution (a nontrivial conceptual problem in ML-for-biology).
    • “A Sitewise Model of Natural Selection on Individual Antibodies via a Transformer–Encoder”: sitewise selection modeling implies attention/transformer architectures tied to evolutionary interpretability.
    • “larch: mapping the parsimony-optimal landscape of trees for directed exploration”: indicates algorithmic and complexity-aware computational phylogenetics.
    However, because the actual paper DOIs/full texts are not provided for these titles in the input, I cannot verify methods/results/limitations from primary sources here.

    Critical scientific appraisal (what we can and cannot conclude)

    What is reasonably supported:
    • Low measured impact (early-stage): the provided metrics (h-index=2; total citations=5) point to a limited citation footprint so far. The OpenAlex candidate record with h_index=2 and works_count=3 aligns with an early impact profile.
    • Attribution uncertainty is a primary limitation: the presence of multiple similarly named records—including a very different high-output ‘St Louis’ profile—means conclusions about “this author’s work” could be misassigned if the disambiguation is wrong.
    What is NOT supported (needs primary papers):
    • Scientific rigor of specific claims: without DOIs/full texts for the author’s listed papers, I cannot evaluate sample sizes, controls, baselines, ablations, reproducibility, or whether conclusions are overextended.
    • Novelty beyond title-level inference: novelty is not reliably assessed from titles alone; novelty requires method/result comparison against prior art (and citations/benchmarks), which are absent here.
    • Reproducibility: reproducibility quality cannot be scored from metadata alone; code/data availability and validation breadth are unknown.

    Blinds spots & potential failure modes (skeptical checklist)

    • Name disambiguation / author-merging: OpenAlex shows multiple “David Rich / David H Rich” candidates. A merged identity could distort metrics and paper lists.
    • Citation metrics aren’t mechanistic proof: early papers can be highly rigorous yet not widely cited; conversely, widely cited papers can still have fragility. Metrics here are only a weak proxy for quality.
    • Domain drift across candidates: given the disambiguation risk, “biological merit” for this specific David H Rich might differ substantially from any other same-name candidate.

    Actionable next steps to make the review decisive

    1. Confirm the correct identity using ORCID (if available) or by matching affiliations and coauthor networks.
    2. For each of the listed titles, retrieve DOI + full text; then evaluate: baselines, ablations, negative controls, computational reproducibility (code, seeds), and whether “selection vs mutation” disentanglement is empirically falsified in cross-datasets.
    3. Score each paper for: (i) data provenance, (ii) validation breadth, (iii) robustness to hyperparameters / training data shifts, and (iv) whether stated conclusions require extra assumptions.


    Feedback:    

    Updated: April 11, 2026

     Top Data Sources ExportMCP


     Science Art


    Author Review: David H Rich Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending